Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00072072 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: celecoxib
DRUG: erlotinib hydrochloride

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]